Background and objective: Staphylococcus aureus (S. aureus) is responsible for a wide range of diseases and increased number of the strains that acquired resistance to antibiotics. The emergence of Vancomycin resistance of S. aureus has been a significant impact on human health. The distribution of Vancomycin minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) in S. aureus isolates, and compared antibiotic susceptibility to non-glycopeptideantibiotics in different Vancomycin MIC value groupswere assessed in this study. Methods: S. aureuswere isolated by standard method and subjected to MIC tested by broth microdilution method for Vancomycin and eight non-glycopeptideantibiotics, alsoVancomycin MBCs were determined. Results: Approximately 56% of S. aureus with a 0.5 µg/ml Vancomycin MIC were accounted, whereas 1.77% of S. aureushadan 8 µg/ml Vancomycin MIC. In other hand, most S. aureus had 1 and 2 µg/ml Vancomycin MBC. Conclusion: About half of the S. aureus isolates had 0.5 µg/ml of Vancomycin MIC. Relationship between Vancomycin MIC and resistance to non-glycopeptideantibiotics were observed, with increased Vancomycin MIC, the resistance to others antibiotics also elevated, and vice versa.
Introduction
Clinicians are continually being challenged by infections caused by S. aureus, and remained a serious threat to human health 1,2 . The strain of S. aureus had been major cause of both community-acquired and health care-associated infections, and causes a severe financial burden for health systems 3,4 .S. aureushas been a continuing threat because of the emergence of antibiotic resistance and particularly efficient at developing resistance to antibiotics 5,6 . In addition, the treatment of suspected S. aureusinfections is becoming increasingly more complicated 1 . An important distinctive feature of S. aureusstrains is the susceptibility to methicillin, strains are categorised intothe methicillinsensitive S. aureus (MSSA) and methicillinresistant S. aureus (MRSA) 7,8 . Therefore, most MRSA strains are multidrug resistant 9,10 . Currently, measures to control S. aureus infections are challenged by a large and continuing increase in the prevalence of MRSA worldwide [11] [12] [13] . The glycopeptide antibiotic Vancomycinis believed to be the most effective antibiotic against S. aureus, and it has been widely used for the treatment of MRSA infections for a long time [14] [15] [16] . Van comycin has been the most reliable therapy for serious S. aureus and MRSA infections [17] [18] [19] . Consequently, the widespread occurrence of S. aureusmade the increased use of Vancomycin inevitable, and this has resulted in a selective pressure and the emergence of S. aureus with reduced susceptibility to Vancomycin 5,11,20 . Nevertheless, intermediate or full resistance to Vancomycin has emerged recently in S. aureus and MRSA 21, 22 . Definition of Vancomycin resistance is controversial of which confusion over the definitions of Vancomycin resistance has been generated by recent literature. The source of this confusion seems to be the different breakpoints in Vancomycin susceptibilities used in various countries [23] [24] [25] [26] [27] [28] 36, 37 . Furthermore, breakpoints may allow for shifts in MIC populations to go unrecognized unless there is a change in the categorical interpretation 22,38 . Vancomycinhas traditionally been considered a bactericidal agent, and its potency is reduced to bacteriostatic levels in the setting of high-inoculum infections 37 . Bactericidal activity of Vancomycinis probably essential for effective treatment of highbacterialdensity infections and serious infections in immunocompromised patients 6 . Tolerance describes the ability of a small minority of strains of a bacterial species to exhibit a bacteriostatic response to an antibacterial challenge that is bactericidal for the majority 39 .
Staphylococcus aureus isolates:
Clinical specimens were collected from various specimens taken from patients presented at Hawler, Maternity and Rizgary teaching hospitals in Erbil, Kurdistan Region, Iraq, from June 2011 to November 2012. Only one isolate per patient was included in the study. Patient age less than 18 years, pregnant woman, and patients received immune suppressive drug were excluded from the study. The study was approved by the ethics committee at College of Nursing, Hawler Medical University. The patients were asked to give informed consent before participating in the research. All S. aureus isolates were identified using routine bacteriological procedures, including Gram stain, colony morphology, mannitol fermentation, slide and/ or tube coagulase tests and API STAPH system (bioMérieux, France) 40 .
Determination of minimum inhibitory concentration
The MIC values of Vancomycin was determined by a broth microdilution method to all S. aureus isolates at concentrations 0.25 to 32 µg/ml, which performed in sterile flatbottom 96-well microplates (Costar NY, USA), as described in CLSI guidelines (41) . In addition, the microdilution method applied on eight non-glycopeptide antibiotics, which included Gentamicin, Amikacin, Tobramycin, Azithromycin, Clarithromycin, Ciprofloxacin, Gatifloxacin, Levofloxacin, and Moxifloxacin (Sigma-Aldrich). The microplates were incubated at 35°C andthe MIC end points were read visually following 24 h of incubation. MIC defined as the lowest concentration of the antibiotic that were inhibit the growth of S. aureus being tested as detected by lack of visual turbidity compared with antibiotic-free growth control. The resistant of S. aureusto nonglycopeptidewas determined according to CLSI documents M100-S19 42 .
Vancomycinminimum bactericidal concentrationdetermination
The MBC for Vancomycin were defined as 99.9% killing of the initial inoculum after 24 h of incubation 43 . Following a broth microdilution MIC assay, from each well that shows no growth, 100 µl of suspension were removed and spread onto blood agar plates. The plates were incubated overnight at 35ºC. The number of colonies growing from each of the wells was Methods counted and the number of colonies corresponded to a thousand-fold reduction, as compared to the colony count of the start inoculum was recorded as the MBC [44] [45] [46] . Repeat testing was conducted on those isolates with MBCs ≥ 16 µg/ml to confirm the result.
Vancomycin tolerance
Vancomycin tolerance was defined as an MBC: MIC ratio ≥ 32 44, 45, 47 .
Statistical method
Statistical package for social sciences (SPSS) version 18.0 was used to perform the analysis. Statistic Tables containing percentages and statistical values. A mean±SD (standard deviation) values was done to MIC and MBC. Pearson Chi-Square was used to compare nonglycopeptide antibiotic resistance among Vancomycin MICs value groups. One-Way ANOVA with Duncan test were used to compare the MICs of antibiotic among the different groups. The level of statistical significance was set at P<0.05.
A total of 453 S. aureus isolated, which were grouped from A to E according to Vancomycin MIC values of which Vancomycin MIC of 0.5, 1, 2, 4, and 8 µg/ml are grouped into A, B, C, D and E, respectively. Three isolates (0.66%) had 0.25 µg/ml MIC to Vancomycin were non-grouped. High percentage (55.85%)of the isolates had 0.5 µg/ml MIC to Vancomycin, whereas only eight strains (1.77%) had MIC 8 µg/ml. MIC of 16, and 32 µg/ml were not recorded, Table 1. The Vancomycin MBC for S. aureus isolates ranged from 0.5 to 32 µg/ml, 247 (54.53%) of the strains had Vancomycin MBCs of 1 µg/ml, where as only one isolates (0.22%) had MBC of 32 µg/ml, Table  2 . The susceptibility of S. aureus isolates to various non-glycopeptide antibiotics was likely to be associated with Vancomycin MICs value. The isolates with Vancomycin MICs of 4 and 8 µg/ml (groups D and E) revealed high resistance to other antibiotics Table 3 . Statistical analysis showed that the differences to all non-glycopeptideantibiotics resistance were significant (P<0.001) among groups A to E, except Tobramycin (P= 0.105). Statistical comparisons between groups of Vancomycin MIC value (A to E groups) were done by One-Way ANOVA with Duncan test at P<0.05 for compared different groups to each non-glycopeptideantibiotic are show inTable 4. Mean MICof Gentamicin in groups E were statistically higher than groups A, B, C, and D. Furthermore, no significant differences were observed between groups C, D and E to Clarithromycin. S. aureus is considered as a major human pathogen responsible for a wide range of serious acute and chronic diseases, its increasing antibiotic resistance, contribute to its success as an infective agent 48, 49 
